Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Current doctor's diagnosis of generalized anxiety disorder
In need of psychiatric treatment
Willingness to complete all aspects of the study
You may not be if
Current doctor's diagnosis of major depression
History of schizophrenia or schizoaffective disorders
Drug dependence within 2 months prior to study start
For detailed information on eligibility, please contact the study center nearest to you (see below), or call 1-862-778-8300, or visit the following website:
www.novartisclinicaltrials.com
Clareo Health | Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
